… serum YKL-40 and HER2 had the poorest median survival of … 32 months for patients with
normal serum YKL-40 and HER2. … YKL-40 in an independent prognostic factor for poor survival …

… found an elevated serum YKL-40 to be an independent prognostic factor for poor survival
in patients with metastatic melanoma. When combining the levels of serum YKL-40 and LDH, …

… high serum YKL-40 levels were related to short recurrence-free interval and poor survival
of … The median survival time for the patients with elevated serum YKL-40 was 5.1 months …

… It has been suggested that high serum YKL-40 levels might be useful as an independent
preoperative predictor for poor survival in patients with colorectal carcinoma.22 However, a …

… YKL-40 and a poor prognosis has been well documented [Citation5,Citation7,Citation8], but
the specific relationship between levels of YKL-40 and survival in … of YKL-40 and survival in …

… of YKL-40 and outcome. However, YKL-40 is a prognostic biomarker of poor survival in other
… a significant impact on the association of serum YKL-40 and survival found in this study. …

… and short overall survival, and that high serum YKL-40 was an independent prognostic
factor of poor survival. In patients treated surgically for colorectal cancer, a high serum YKL-40 …

… value of pretreatment serum YKL-40 levels for survival in patients with metastatic NSCLC. …
a high serum YKL-40 level was an independent prognostic biomarker of poor survival in this …

… YKL-40 was also strongly associated with poor survival, as only the metastatic status of the
… YKL-40 was found to be a statistically significant independent risk factor for poor survival in …

… The available evidence supports the hypothesis that elevated serum/plasma YKL-40 is
associated with poor survival in patients with solid tumors and that serum/plasma YKL-40 may …